These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 34128045)

  • 21. Reduced nitric oxide bioavailability mediates cerebroarterial dysfunction independent of cerebral amyloid angiopathy in a mouse model of Alzheimer's disease.
    Merlini M; Shi Y; Keller S; Savarese G; Akhmedov A; Derungs R; Spescha RD; Kulic L; Nitsch RM; Lüscher TF; Camici GG
    Am J Physiol Heart Circ Physiol; 2017 Feb; 312(2):H232-H238. PubMed ID: 27836896
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cerebral Amyloid Angiopathy in a Mouse Model of Alzheimer's Disease Associates with Upregulated Angiopoietin and Downregulated Hypoxia-Inducible Factor.
    Skaaraas GHES; Melbye C; Puchades MA; Leung DSY; Jacobsen Ø; Rao SB; Ottersen OP; Leergaard TB; Torp R
    J Alzheimers Dis; 2021; 83(4):1651-1663. PubMed ID: 34459401
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prominent amyloid plaque pathology and cerebral amyloid angiopathy in APP V717I (London) carrier - phenotypic variability in autosomal dominant Alzheimer's disease.
    Lloyd GM; Trejo-Lopez JA; Xia Y; McFarland KN; Lincoln SJ; Ertekin-Taner N; Giasson BI; Yachnis AT; Prokop S
    Acta Neuropathol Commun; 2020 Mar; 8(1):31. PubMed ID: 32164763
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term voluntary wheel running does not alter vascular amyloid burden but reduces neuroinflammation in the Tg-SwDI mouse model of cerebral amyloid angiopathy.
    Robison LS; Popescu DL; Anderson ME; Francis N; Hatfield J; Sullivan JK; Beigelman SI; Xu F; Anderson BJ; Van Nostrand WE; Robinson JK
    J Neuroinflammation; 2019 Jul; 16(1):144. PubMed ID: 31296239
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-Aβ Antibodies and Cerebral Amyloid Angiopathy Complications.
    Chantran Y; Capron J; Alamowitch S; Aucouturier P
    Front Immunol; 2019; 10():1534. PubMed ID: 31333665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microglia-mediated T cell infiltration drives neurodegeneration in tauopathy.
    Chen X; Firulyova M; Manis M; Herz J; Smirnov I; Aladyeva E; Wang C; Bao X; Finn MB; Hu H; Shchukina I; Kim MW; Yuede CM; Kipnis J; Artyomov MN; Ulrich JD; Holtzman DM
    Nature; 2023 Mar; 615(7953):668-677. PubMed ID: 36890231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of suppressive oligodeoxynucleotides that inhibit Toll-like receptor-9-mediated activation of innate immunity.
    Peter M; Bode K; Lipford GB; Eberle F; Heeg K; Dalpke AH
    Immunology; 2008 Jan; 123(1):118-28. PubMed ID: 17961163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunostimulatory Activities of CpG-Oligodeoxynucleotides in Teleosts: Toll-Like Receptors 9 and 21.
    Lai CY; Yu GY; Luo Y; Xiang R; Chuang TH
    Front Immunol; 2019; 10():179. PubMed ID: 30800129
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oligomeric Abeta in Alzheimer's disease: relationship to plaque and tangle pathology, APOE genotype and cerebral amyloid angiopathy.
    van Helmond Z; Miners JS; Kehoe PG; Love S
    Brain Pathol; 2010 Mar; 20(2):468-80. PubMed ID: 19725829
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tau pathology-dependent remodelling of cerebral arteries precedes Alzheimer's disease-related microvascular cerebral amyloid angiopathy.
    Merlini M; Wanner D; Nitsch RM
    Acta Neuropathol; 2016 May; 131(5):737-52. PubMed ID: 26988843
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A shift in microglial β-amyloid binding in Alzheimer's disease is associated with cerebral amyloid angiopathy.
    Zabel M; Schrag M; Crofton A; Tung S; Beaufond P; Van Ornam J; Dininni A; Vinters HV; Coppola G; Kirsch WM
    Brain Pathol; 2013 Jul; 23(4):390-401. PubMed ID: 23134465
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases.
    Sasaki N; Fukatsu R; Tsuzuki K; Hayashi Y; Yoshida T; Fujii N; Koike T; Wakayama I; Yanagihara R; Garruto R; Amano N; Makita Z
    Am J Pathol; 1998 Oct; 153(4):1149-55. PubMed ID: 9777946
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Absence of microglia promotes diverse pathologies and early lethality in Alzheimer's disease mice.
    Kiani Shabestari S; Morabito S; Danhash EP; McQuade A; Sanchez JR; Miyoshi E; Chadarevian JP; Claes C; Coburn MA; Hasselmann J; Hidalgo J; Tran KN; Martini AC; Chang Rothermich W; Pascual J; Head E; Hume DA; Pridans C; Davtyan H; Swarup V; Blurton-Jones M
    Cell Rep; 2022 Jun; 39(11):110961. PubMed ID: 35705056
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunotherapeutic approaches for Alzheimer's disease in transgenic mouse models.
    Wisniewski T; Boutajangout A
    Brain Struct Funct; 2010 Mar; 214(2-3):201-18. PubMed ID: 20012091
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
    Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
    Elife; 2020 Jun; 9():. PubMed ID: 32510331
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cerebral amyloid angiopathy is a pathogenic lesion in Alzheimer's disease due to a novel presenilin 1 mutation.
    Dermaut B; Kumar-Singh S; De Jonghe C; Cruts M; Löfgren A; Lübke U; Cras P; Dom R; De Deyn PP; Martin JJ; Van Broeckhoven C
    Brain; 2001 Dec; 124(Pt 12):2383-92. PubMed ID: 11701593
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cerebral amyloid angiopathy and its co-occurrence with Alzheimer's disease and other cerebrovascular neuropathologic changes.
    Brenowitz WD; Nelson PT; Besser LM; Heller KB; Kukull WA
    Neurobiol Aging; 2015 Oct; 36(10):2702-8. PubMed ID: 26239176
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Origins of Beta Amyloid Differ Between Vascular Amyloid Deposition and Parenchymal Amyloid Plaques in the Spinal Cord of a Mouse Model of Alzheimer's Disease.
    Yuan Q; Liu X; Xian YF; Tang Y; Zou J; Zhang X; Huang P; Wu W; Song YQ; Lin ZX
    Mol Neurobiol; 2020 Jan; 57(1):278-289. PubMed ID: 31325023
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Only cerebral capillary amyloid angiopathy correlates with Alzheimer pathology--a pilot study.
    Attems J; Jellinger KA
    Acta Neuropathol; 2004 Feb; 107(2):83-90. PubMed ID: 14655019
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vaccination as a therapeutic approach to Alzheimer's disease.
    Wisniewski T; Boutajangout A
    Mt Sinai J Med; 2010; 77(1):17-31. PubMed ID: 20101719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.